2.79 USD
↘ 0.12 (4.13%)LIVE (AS OF 11:24 AM EST)
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) is currently trading at $2.79. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. RXRX is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 16, 2026.